Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma, with special reference to PD-1 expression-Reference-Cited by-同舟云学术

Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma, with special reference to PD-1 expression

Published:2023-04-15 Issue:8 Volume:72 Page:2585-2596
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Furuya Tatsuo,Ishihara Shunta,Ogi Hiroshi,Masuda Kyoko,Shibata Saya,Nakazono Chiaki,Okada Satoru,Shimomura Masanori,Tando So,Yaoi Takeshi,Maeda Yoshinobu,Yamagishi Masaaki,Kawamoto Hiroshi,Itoh Kyoko,Inoue Masayoshi^ORCID

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-023-03431-5.pdf

Reference35 articles.

1. Marx A, Chan JKC, Chalabreysse L et al (2022) The 2021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors? J Thorac Oncol 17:200–213

2. Kondo K, Monden Y (2003) Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 76:878–884

3. Falkson CB, Vella ET, Ellis PM et al (2022) Surgical, radiation, and systemic treatments of patients with thymic epithelial tumours: a clinical practice guideline. J Thorac Oncol 17:1258–1275

4. Cho J, Kim HS, Ku BM et al (2019) Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial. J Clin Oncol 37:2162–2170

5. Giaccone G, Kim C, Thompson J et al (2018) Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study. Lancet Oncol 19:347–355

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type B thymomas in patients with myasthenia gravis display a distinctive pattern of αβ TCR and IL-7 receptor α expression on CD4 ⁺ CD8 ⁺ thymocytes;Autoimmunity;2024-04-27

2. In-depth blood immune profiling of Good syndrome patients;Frontiers in Immunology;2023-11-15